As the semi-legal peptide sector explodes, driven by a confluence of online trends like "looksmaxing" and the "Make America Healthy Again" movement, more and more suppliers and buyers are turning to cryptocurrency, Chainalysis said Thursday in a new report.
According to the analysis firm, the appetite for off-label peptides — the building blocks of proteins used as a dietary supplement, and across the health, wellness, and fitness spaces — has surged past a $100 million annual run rate. The first quarter of 2026 alone saw a 159% quarter-over-quarter jump to $32 million from $12 million, according to Chainalysis' report.
What started as a niche interest among biohackers has entered the public conversation, primarily driven by the success of GLP-1 peptide drugs like Ozempic and Wegovy, leading to search interest for other solutions that can be used for anything from suppressing appetite to repairing cell damage.
And like the other so-called research chemical "gray market," where derivatives of illicit drugs like fentanyl are sold online often via crypto, the peptide trade is increasingly dominated by Chinese chemical manufacturers, which are often cut off from the traditional banking sector, according to Chainalysis.
